17. Diabetes Advocacy: Standards of Medical Care in Diabetes—2022
Open accessAbstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In subjects with diabetes or obesity, exercise increases insulin sensitivity independently of changes in body fat with nutritional interventions.
“In subjects with diabetes or obesity, exercise is the cornerstone of therapeutic interventions. It increases insulin sensitivity independently of changes in body fat with nutritional interventions”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [242]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited by
Sorted by citations
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351 · see citing works
Dobrowolski, P., Prejbisz, A., Kuryłowicz, A., Baska, A., Burchardt, P., Chlebus, K., Dzida, G. J., Jankowski, P., Jaroszewicz, J., Jaworski, P., et al. (2022) · Archives of Medical Science · doi:10.5114/aoms/152921 · Cited by 203 · see citing works
“Metformin should be considered to prevent the development of type 2 diabetes mellitus in following groups of patients with pre-diabetes: those aged 60 with BMI ≥ 35 kg/m 2 , and women with history of gestational diabetes [32, 33].”
BackgroundPapakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199 · see citing works
Physical activity in metabolic syndrome
Chomiuk, T., Niezgoda, N., Mamcarz, A., & Śliż, D. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1365761 · Cited by 135 · see citing works
“The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) and International Diabetes Federation (IDF) de fi nitions take the presence of obesity, dyslipidemia, elevated blood pressure and elevated fasting glucose levels as diagnostic criteria (Grundy et al., 2005; Alberti et al., 2006).”
MethodInfluentialMetabolic syndrome — a new definition and management guidelines
Dobrowolski, P., Prejbisz, A., Kuryłowicz, A., Baska, A., Burchardt, P., Chlebus, K., Dzida, G. J., Jankowski, P., Jaroszewicz, J., Jaworski, P., et al. (2022) · Arterial Hypertension · doi:10.5603/ah.a2022.0012 · Cited by 53 · see citing works
Matsuzawa, Y., Azuma, K., Sawa, T., Ono, Y., Hamada, Y., Matsuba, I., & Kanamori, A. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13891 · Cited by 12 · see citing works
Cai, T., Yue, T., Xu, M., Zhang, P., Wang, Y., Liu, Q., Huang, J. M., Shen, T., Yin, Q., Sheng, Z., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28635 · Cited by 8 · see citing works
Xu, M., Sun, K., Xu, W., Wang, C., Yan, D., Li, S., Cong, L., Pi, Y., Song, W., Sun, Q., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-03089-x · Cited by 5 · see citing works
Kuo, H., Huang, Y., Wu, S.-W., et al. (2022) · Medicina · doi:10.3390/medicina58050577 · Cited by 5 · see citing works
The Impact of War and Conflict on People Living with Diabetes: A Scoping Review
OSPELT, E. L., Mungmode, A., Hardison, H., et al. (2024) · Clinical Diabetology · doi:10.5603/cd.100617 · Cited by 4 · see citing works
Adherencia a las medidas higiénico dietéticas de adultos con diabetes mellitus de Asunción en 2022
Mello, L. C. R., Fernández, A. L. A., González, T. M. A., et al. (2023) · Revista Virtual de la Sociedad Paraguaya de Medicina Interna · doi:10.18004/rvspmi/2312-3893/2023.10.01.20 · Cited by 3 · see citing works
Elaidy, S. M., Samman, F. S., & Imbaby, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815322132125010015 · Cited by 1 · see citing works
Yu, N., Xu, W., Guo, X., Xu, M., Zhang, W., Yan, C., Pang, S., Shu, X., Zhang, W., Peng, W., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16427 · Cited by 1 · see citing works
Romaniv, T. V., Skrypnyk, N. V., Synko, U. V., Voronych-Semchenko, N., Melnyk, O. V., Hryb, A. O., & Boruchok, I. B. (2023) · Wiadomości Lekarskie · doi:10.36740/wlek202306109 · Cited by 1 · see citing works
Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery in High-Risk Surgeries
Parrish, R. H., & Findley, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-56270-9_29
Study of Antidiabetic Potential of Polyherbal Formulation
Varal Neeta., R., & Kiran.S, M. L. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-29960
- Authors
- American Diabetes Association Professional Practice Committee
- Corresponding author
- American Diabetes Association Professional Practice Committee
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-12-16
- Volume
- 45
- Issue
- Supplement_1
- Pages
- S254-S255
- ISSN
- 0149-5992 (ISSN-L)
- OpenAlex
- W4200052525
- Cited by
- 32
- References
- 0
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 6 · 2022: 10 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 2
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetes advocacy, clinical guidelines, diabetes management guidelines, quality of care evaluation, level of evidence, treatment goals
- MeSH terms
- Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
